These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 13625640)

  • 1. First results of dopane therapy of chronic myeloid leukemia and of certain malignant tumors.
    VISHNIAKOVA EG
    Vopr Onkol; 1958; 4(5):569-72. PubMed ID: 13625640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Result of use of dopan in treatment of chronic myeloleukosis].
    MOKEEVA RA
    Sov Med; 1958 Sep; 22(9):42-6. PubMed ID: 13615483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Kinetic criteria of the effectiveness of treatment of chronic myeloleukosis].
    Levitin EI; Kukharenko IuA; Gor'kov VA; Evseenko LS
    Izv Akad Nauk SSSR Biol; 1973; 4():566-72. PubMed ID: 4518679
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of chronic myelogenous leucaemia treated with nitrogen mustard N-oxide].
    KUROYANAGI S
    Gan; 1953 Sep; 44(2-3):397-8. PubMed ID: 13128215
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination of microdosage of chloralkylamines with roentgen irradiation in the treatment of hemoblastoses and hemoblastomas].
    VESIN S
    Cas Lek Cesk; 1952 Nov; 91(45-46):1384-7. PubMed ID: 14390440
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary results of combined urethane, nitrogen mustard and Delbet's vaccine therapy of chronic myelocytic leukemias].
    SZREDER W; MIGDALSKA Z
    Pol Tyg Lek (Wars); 1951 May; 6(18-19):620-4. PubMed ID: 14875527
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experiences with clinical use of some new chemotherapeutics in tumor therapy].
    PEREVODCHIKOVA NJ
    Dtsch Med Wochenschr; 1958 Jan; 83(1):21-3. PubMed ID: 13500993
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological actions and therapeutic applications of nitrogen mustard.
    BEATTIE JW; HOWELLS LH
    Q J Med; 1954 Apr; 23(90):231-54. PubMed ID: 13155775
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary data on application of dopamine lymphogranulomatosis].
    IVANOVA EM
    Vopr Onkol; 1957; 3(5):556-62. PubMed ID: 13507321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms].
    INGRASSIA G; VASILE B
    Haematologica; 1951; 35(10):907-53. PubMed ID: 14906882
    [No Abstract]   [Full Text] [Related]  

  • 11. [New method of treating patients with rheumatoid arthritis using electrophoresis of the immunosuppressive preparation dopan from a dimexide solution].
    Kozlova LA; Tereshina LG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1986; (1):33-5. PubMed ID: 3518232
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of nitrogen mustard on the oxygen consumption of the leukocytes in chronic myeloid leukemia].
    PISANI A; POGGI C; MEARDI G
    Boll Soc Ital Biol Sper; 1960 Aug; 36():750-2. PubMed ID: 13736043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds].
    CHILOV K; IVANOV S; KIRCHEV P
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1957; 14():73-129. PubMed ID: 13587006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Range of indication for nitrogen mustard oxide in the therapy of malignant tumors].
    BECKER T
    Strahlentherapie; 1957; 15(Sonderbd. 37):279-80. PubMed ID: 13495778
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of subleukemic myeloleukosis with Dopan].
    Morozova VT; Miroshnichenko IS; Terent'eva NI
    Ter Arkh; 1967 Feb; 39(2):19-20. PubMed ID: 5611685
    [No Abstract]   [Full Text] [Related]  

  • 16. [First experience in treating malignant tumors with a new nitrogen mustard-phosphamidester].
    GROSS R; LAMBERS K
    Dtsch Med Wochenschr; 1958 Mar; 83(12):458-62. PubMed ID: 13537668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    ZULIK R
    Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with nitrogen mustards. V. Therapy of malignant tumors].
    CERNIK F; LUKL P; PROCHAZKA J; VIZDA J
    Cas Lek Cesk; 1952 Jan; 91(2):44-9. PubMed ID: 14390080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of treatment of malignant tumors with N-mustard gas-phosphamide ester (endoxan)].
    SCHWENKENBECHER W
    Ther Ggw; 1959 Jun; 98(6):285-7. PubMed ID: 13676100
    [No Abstract]   [Full Text] [Related]  

  • 20. [THE USE OF DOPAN AND MYELOSAN IN THE TREATMENT OF PATIENTS WITH CHRONIC MYELOLEUKEMIA].
    SPASSKII OV
    Sov Med; 1963 May; 26():30-3. PubMed ID: 14073326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.